Suppr超能文献

P-糖蛋白的卓越转运机制:一种多药转运蛋白。

The remarkable transport mechanism of P-glycoprotein: a multidrug transporter.

作者信息

Al-Shawi Marwan K, Omote Hiroshi

机构信息

Department of Molecular Physiology and Biological Physics, University of Virginia Health System, P.O. Box 800736, Charlottesville, Virginia, 22908-0736, USA.

出版信息

J Bioenerg Biomembr. 2005 Dec;37(6):489-96. doi: 10.1007/s10863-005-9497-5.

Abstract

Human P-glycoprotein (ABCB1) is a primary multidrug transporter located in plasma membranes, that utilizes the energy of ATP hydrolysis to pump toxic xenobiotics out of cells. P-glycoprotein employs a most unusual molecular mechanism to perform this drug transport function. Here we review our work to elucidate the molecular mechanism of drug transport by P-glycoprotein. High level heterologous expression of human P-glycoprotein, in the yeast Saccharomyces cerevisiae, has facilitated biophysical studies in purified proteoliposome preparations. Development of novel spin-labeled transport substrates has allowed for quantitative and rigorous measurements of drug transport in real time by EPR spectroscopy. We have developed a new drug transport model of P-glycoprotein from the results of mutagenic, quantitative thermodynamic and kinetic studies. This model satisfactorily accounts for most of the unusual kinetic, coupling, and physiological features of P-glycoprotein. Additionally, an atomic detail structural model of P-glycoprotein has been devised to place our results within a proper structural context.

摘要

人类P-糖蛋白(ABCB1)是一种主要的多药转运蛋白,位于质膜中,利用ATP水解产生的能量将有毒的外源性物质泵出细胞。P-糖蛋白采用一种非常独特的分子机制来执行这种药物转运功能。在此,我们回顾我们的工作,以阐明P-糖蛋白药物转运的分子机制。人类P-糖蛋白在酿酒酵母中的高水平异源表达,促进了对纯化的蛋白脂质体制剂的生物物理研究。新型自旋标记转运底物的开发,使得通过电子顺磁共振光谱实时定量和严格测量药物转运成为可能。我们根据诱变、定量热力学和动力学研究结果,开发了一种新的P-糖蛋白药物转运模型。该模型令人满意地解释了P-糖蛋白的大多数异常动力学、偶联和生理特征。此外,还设计了P-糖蛋白的原子细节结构模型,以便将我们的结果置于适当的结构背景中。

相似文献

1
The remarkable transport mechanism of P-glycoprotein: a multidrug transporter.
J Bioenerg Biomembr. 2005 Dec;37(6):489-96. doi: 10.1007/s10863-005-9497-5.
2
A novel electron paramagnetic resonance approach to determine the mechanism of drug transport by P-glycoprotein.
J Biol Chem. 2002 Nov 22;277(47):45688-94. doi: 10.1074/jbc.M206479200. Epub 2002 Sep 19.
3
Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein.
J Biol Chem. 2003 Dec 26;278(52):52629-40. doi: 10.1074/jbc.M308175200. Epub 2003 Oct 9.
4
Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors.
Science. 2019 May 17;364(6441):689-692. doi: 10.1126/science.aav9406.
7
Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1).
PLoS One. 2013 Dec 5;8(12):e82463. doi: 10.1371/journal.pone.0082463. eCollection 2013.
9
FRET analyses reveal a role of ATP hydrolysis-associated conformational changes in human P-glycoprotein.
J Biol Chem. 2020 Apr 10;295(15):5002-5011. doi: 10.1074/jbc.RA119.012042. Epub 2020 Feb 28.
10
ATP hydrolysis-dependent multidrug efflux transporter: MDR1/P-glycoprotein.
Curr Drug Metab. 2004 Feb;5(1):1-10. doi: 10.2174/1389200043489090.

引用本文的文献

1
ABC Transporters 45 Years On.
Int J Mol Sci. 2023 Nov 27;24(23):16789. doi: 10.3390/ijms242316789.
3
The Alternating Access Mechanism in Mammalian Multidrug Resistance Transporters and Their Bacterial Homologs.
Membranes (Basel). 2023 May 30;13(6):568. doi: 10.3390/membranes13060568.
4
Extended-ensemble docking to probe dynamic variation of ligand binding sites during large-scale structural changes of proteins.
Chem Sci. 2022 Mar 16;13(14):4150-4169. doi: 10.1039/d2sc00841f. eCollection 2022 Apr 6.
5
Inorganic Nanomaterial-Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities.
Adv Funct Mater. 2021 Jan 27;31(5). doi: 10.1002/adfm.202007096. Epub 2020 Oct 13.
6
Theoretical insights on helix repacking as the origin of P-glycoprotein promiscuity.
Sci Rep. 2020 Jun 17;10(1):9823. doi: 10.1038/s41598-020-66587-5.
8
The conformation and dynamics of P-glycoprotein in a lipid bilayer investigated by atomic force microscopy.
Biochem Pharmacol. 2018 Oct;156:302-311. doi: 10.1016/j.bcp.2018.08.017. Epub 2018 Aug 16.
9
A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein.
J Pharm Sci. 2018 Jul;107(7):1937-1947. doi: 10.1016/j.xphs.2018.02.019. Epub 2018 Feb 28.
10
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.
J Med Chem. 2018 Jun 28;61(12):5108-5121. doi: 10.1021/acs.jmedchem.7b01457. Epub 2017 Dec 28.

本文引用的文献

2
Mouse myodulin, a new potential angiogenic factor, functionally expressed in yeast.
Biochem Biophys Res Commun. 2005 Jun 3;331(2):552-6. doi: 10.1016/j.bbrc.2005.04.008.
3
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37. doi: 10.1016/j.taap.2004.10.012.
4
Human receptor Smoothened, a mediator of Hedgehog signalling, expressed in its native conformation in yeast.
FEBS Lett. 2005 Feb 28;579(6):1529-33. doi: 10.1016/j.febslet.2005.01.054.
5
ABC transporters in the balance: is there a role in multidrug resistance?
Biochem Soc Trans. 2005 Feb;33(Pt 1):241-5. doi: 10.1042/BST0330241.
6
ATP-binding cassette transporters in bacteria.
Annu Rev Biochem. 2004;73:241-68. doi: 10.1146/annurev.biochem.73.011303.073626.
7
Improved energy coupling of human P-glycoprotein by the glycine 185 to valine mutation.
Biochemistry. 2004 Apr 6;43(13):3917-28. doi: 10.1021/bi035365l.
8
Val133 and Cys137 in transmembrane segment 2 are close to Arg935 and Gly939 in transmembrane segment 11 of human P-glycoprotein.
J Biol Chem. 2004 Apr 30;279(18):18232-8. doi: 10.1074/jbc.M400229200. Epub 2004 Jan 28.
10
Epitope tagging of the yeast K(+) carrier Trk2p demonstrates folding that is consistent with a channel-like structure.
J Biol Chem. 2004 Jan 23;279(4):3003-13. doi: 10.1074/jbc.M309760200. Epub 2003 Oct 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验